Ex-Genzyme chief Termeer joins board at Cambridge biotech

Tracy Staton

Moderna Therapeutics has scored another coup. The , which struck a major development deal with AstraZeneca ($ AZN) just months after it shed stealth status, has landed former Genzyme CEO Henri for the of directors. Report

FiercePharma News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS